GTHP developed a biophotonic cervical cancer scan that will replace 60 million annual PAP smear tests.
It's noninvasive, more accurate and produces instant test results.
(insiders are buying shares at GTHP)
Hey screen_savior, how is your GALE $7+ purchase doing?
Are you into INOscan too?
You are a double loser?
Ever since you started touting GTHP in October with a new ID, it has went down. Nobody is interested in it or the volume would be there.
Are you looking at the GALE chart?
Down is $7.77 to $3.36.
I endorse this stock, especially at the bargain basement price.
It kinda reminds you of GALE when that was at .50.
You're on the wrong board. This board is for losers.
It looks like they prefer losing all their money here.
Sad, so sad.